Lungcancer Symposium on Targeted Therapy in Lund on September 30, 2025
During this meeting, experts discuss the latest insights in the treatment of targeted therapy in NSCLC with focus on BRAF mutated NSCLC.
Special invited speaker: Professor Niels Reinmuth, Asklepios Lung Clinic Gauting, München
SE-BRH-02-26-2600003